MiQuant® AAV ITR 5 – dPCR

MiQuant® AAV ITR 5 – dPCR
Product Description

The MiQuant® AAV ITR 5 – dPCR kit is an easy to use, rapid and sensitive solution for adeno-associated virus (AAV) vector titer testing based on digital PCR (dPCR).

This kit provides a primer/probe mix that enables specific detection of AAV genotype 5 by amplifying the respective inverted terminal repeat (ITR) region and is compatible with various dPCR and ddPCR devices (QIAcuity®, ddPCR™, Quantstudio™ Absolute Q™).

The integrated TruTiter™ technology (powered by Promega) ensures that only the DNA packaged within intact AAV capsids is amplified, while free DNA and DNA from broken capsids remain masked and undetectable. This enables highly precise measurement of AAV vector genome titer and eliminates the need for a DNase treatment step.

Read more Show less

Minerva Biolabs GmbH

  • Country/Region:
    Germany
  • Founded:
    1999
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Technology
View company profile
Categories
more categories Show less
Specifications
  • Details
    Intended for adeno-associated virus (AAV) vector titer testing based on digital PCR.
    - Suitable for ITR 5
    - In-process control and release testing
    - TruTiter™ technology allows highly accurate results by only amplifying DNA in intact capsids
    - No DNA extraction or standard curve required
  • Model
    Digital PCR (dPCR and ddPCR™)
More specifications Fewer specifications

Minerva Biolabs GmbH

  • Country/Region:
    Germany
  • Founded:
    1999
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Technology
View company profile

More Products from Minerva Biolabs GmbH (4)

  • 100GC® Mycoplasma Standards

    Product 100GC® Mycoplasma Standards

    100GC® Mycoplasma Standards are non-infectious, purified nucleic acid reference materials with a defined target amount of ≤100 genome copies (GC). They are specifically designed for the validation, verification, and routine performance monitoring of NAT-based mycoplasma detection methods in regulated and r...
  • MiQuant® AAV ITR 2/6 – dPCR

    Product MiQuant® AAV ITR 2/6 – dPCR

    The MiQuant® AAV ITR 2/6 – dPCR kit is an easy to use, rapid and sensitive solution for adeno-associated virus (AAV) vector titer testing based on digital PCR (dPCR).

    This kit provides a primer/probe mix that enables specific detection of AAV genotypes 2 and 6 by amplifying the respectiv...
  • MiQuant® Residual DNA HEK-293 – dPCR

    Product MiQuant® Residual DNA HEK-293 – dPCR

    The MiQuant® Residual DNA HEK-293 – dPCR is suitable for the quantitative detection of residual DNA from host cells in chemical and biological matrices. This kit contains a specific primer/probe mix and provides an open platform solution for use on various dPCR instruments (QIAcuity®, ddPCR™, Quant...
  • Venor® Mycoplasma qPCR

    Product Venor® Mycoplasma qPCR

    Venor® Mycoplasma qPCR is a validated real-time RT-qPCR kit for the rapid, sensitive, and reliable detection of mycoplasma contamination in cell cultures, biopharmaceutical products, and advanced therapy medicinal products (ATMPs). The assay detects both RNA and DNA targets, providing enhanced sensitivity ...

Minerva Biolabs GmbH resources (2)

  • Minerva Biolabs Supports Compliance with the Updated EP 2.6.7 Requirements

    News Minerva Biolabs Supports Compliance with the Updated EP 2.6.7 Requirements

    The revised EP 2.6.7 chapter introduces new expectations for NAT-based mycoplasma testing. With validated PCR assays, extraction kits, and reference standards, Minerva Biolabs offers comprehensive solutions to help laboratories efficiently implement and validate compliant workflows according to the latest European Pharmacopoeia requirements.
    21 May 2026
  • Minerva Biolabs Company Brochure

    Brochure Minerva Biolabs Company Brochure

    Discover Minerva Biolabs’ portfolio of mycoplasma detection and cell culture contamination control solutions for pharmaceutical, biotechnology, and research applications.